{"id":"W1977529605","doi":"10.1007/s10637-014-0066-9","title":"Phase II trial of vorinostat in advanced melanoma","year":2014,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Cancer Research UK","keywords":"Vorinostat; Clinical endpoint; Medicine; Melanoma; Adverse effect; Nausea; Internal medicine; Oncology; Progressive disease; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Chemotherapy; Randomized controlled trial; Cancer research; Histone deacetylase; Histone; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002720192,0.0001026915,0.000138562,0.00008720784,0.00004325915,0.000005560644,0.0001613648,0.00009162404,0.00002574477],"category_scores_gemma":[0.0005442444,0.0001083414,0.00005725551,0.0001430861,0.0001487996,0.000006189319,0.00008255655,0.00009426964,0.00001176159],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001898403,"about_ca_system_score_gemma":0.000362727,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006564074,"about_ca_topic_score_gemma":0.00003610051,"domain_scores_codex":[0.9989014,0.00009041202,0.0002934649,0.0002544885,0.0002849122,0.0001753477],"domain_scores_gemma":[0.9994175,0.00004174791,0.00008528701,0.0002332496,0.00007768713,0.000144568],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004930331,0.0005958447,0.0002448712,0.00001978073,0.00001904498,0.000001956421,0.0003173411,0.0002982953,0.9630648,0.002430566,0.008904379,0.01917281],"study_design_scores_gemma":[0.05816162,0.00296313,0.000172184,0.00002992549,0.000004130925,0.000003287784,0.00002092339,0.0003055062,0.8603813,0.001879724,0.07589846,0.0001798332],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968157,0.00006515478,0.0001335768,0.0006453512,0.0001462795,0.0002332507,0.00002038574,0.000006202658,0.001934096],"genre_scores_gemma":[0.9950412,0.000008320842,0.002278451,0.0001571133,0.0004000496,0.00002313318,0.0002246818,0.00001480947,0.001852276],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1026835,"threshold_uncertainty_score":0.4418035,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01300294792304773,"score_gpt":0.2994760520324806,"score_spread":0.2864731041094329,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}